162 related articles for article (PubMed ID: 6321628)
1. Acute in-vivo effects of adrenocorticotrophin on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits: involvement of the alpha-adrenergic nervous system.
Knudtzon J
J Endocrinol; 1984 Mar; 100(3):345-52. PubMed ID: 6321628
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
[TBL] [Abstract][Full Text] [Related]
3. Alpha-melanocyte stimulating hormone increases plasma levels of glucagon and insulin in rabbits.
Knudtzon J
Life Sci; 1984 Feb; 34(6):547-54. PubMed ID: 6141515
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits--influences of selective blocking drugs.
Knudtzon J
Acta Physiol Scand; 1984 Mar; 120(3):353-61. PubMed ID: 6146241
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits.
Knudtzon J
Horm Metab Res; 1985 Feb; 17(2):53-7. PubMed ID: 3921449
[TBL] [Abstract][Full Text] [Related]
6. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
[TBL] [Abstract][Full Text] [Related]
7. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
Knudtzon J
Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
[TBL] [Abstract][Full Text] [Related]
9. Insulin releasing effects of adrenocorticotropin (ACTH 1-39) and ACTH fragments (1-24 and 18-39) in lean and genetically obese hyperglycaemic (ob/ob) mice.
Bailey CJ; Flatt PR
Int J Obes; 1987; 11(2):175-81. PubMed ID: 3038765
[TBL] [Abstract][Full Text] [Related]
10. Effects of alpha-and beta-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin glucagon and growth hormone responses to prostaglandin E1 in man.
Giugliano D; Torella R; Sgambato S; D'Onofrio F
J Clin Endocrinol Metab; 1979 Feb; 48(2):302-8. PubMed ID: 429484
[No Abstract] [Full Text] [Related]
11. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
12. Effects of somatostatin and adrenergic blockade on glucagon, insulin and glucose in exercising sheep.
Brockman RP; Halvorson R
Aust J Biol Sci; 1981; 34(5-6):551-60. PubMed ID: 6122438
[TBL] [Abstract][Full Text] [Related]
13. Catecholamines in prevention of hypoglycemia during exercise in humans.
Marker JC; Hirsch IB; Smith LJ; Parvin CA; Holloszy JO; Cryer PE
Am J Physiol; 1991 May; 260(5 Pt 1):E705-12. PubMed ID: 1674642
[TBL] [Abstract][Full Text] [Related]
14. Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
Knudtzon J
Horm Metab Res; 1986 Aug; 18(8):505-9. PubMed ID: 2944808
[TBL] [Abstract][Full Text] [Related]
15. Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep.
Muggaberg J; Brockman RP
Res Vet Sci; 1982 Jul; 33(1):118-20. PubMed ID: 6753074
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation.
Raptis S; Escobar-Jimenez F; Rosenthal J; Ditschuneit HH; Pfeiffer EF
J Clin Endocrinol Metab; 1977 Jun; 44(6):1088-93. PubMed ID: 874045
[TBL] [Abstract][Full Text] [Related]
17. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic influence on glucocounterregulation in man.
Lilavivat U; Brodows RG; Campbell RG
Diabetologia; 1981 Apr; 20(4):482-8. PubMed ID: 7016643
[TBL] [Abstract][Full Text] [Related]
19. Glucose uptake during centrally induced stress is insulin independent and enhanced by adrenergic blockade.
Lekas MC; Fisher SJ; El-Bahrani B; van Delangeryt M; Vranic M; Shi ZQ
J Appl Physiol (1985); 1999 Aug; 87(2):722-31. PubMed ID: 10444633
[TBL] [Abstract][Full Text] [Related]
20. The metabolic and endocrine effects of circulating catecholamines in fetal sheep.
Jones CT; Ritchie JW
J Physiol; 1978 Dec; 285():395-408. PubMed ID: 217988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
